The European Journal of Health Economics

2002 - 2025

Current editor(s): J.-M.G.v.d. Schulenburg

From:
Springer
Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ)
Contact information at EDIRC.
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

Access Statistics for this journal.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 24, issue 9, 2023

EQ-5D-5L Portuguese population norms pp. 1411-1420

Pedro Ferreira, Luís N. Pereira, Patrícia Antunes and Lara N. Ferreira

Early start of anti-dementia medication is associated with lower health and social care costs in Alzheimer´s patients: a Finnish nationwide register study pp. 1421-1428

Aino Vesikansa, Olli Halminen, Juha Mehtälä, Iiris Hörhammer, Teija Mikkola, Tero Ylisaukko-oja and Miika Linna

Public preferences for policies promoting a healthy diet: a discrete choice experiment pp. 1429-1440

C. M. Dieteren, I. Bonfrer, Werner Brouwer and J. Exel

A European multinational cost-effectiveness analysis of empagliflozin in heart failure with reduced ejection fraction pp. 1441-1454

Ali Tafazzoli, Odette S. Reifsnider, Leana Bellanca, Jack Ishak, Marc Carrasco, Pal Rakonczai, Matthew Stargardter and Stephan Linden

Cost-effectiveness of ravulizumab compared with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria in the Netherlands pp. 1455-1472

S. W. Quist, A. J. Postma, K. J. Myrén, L. A. Jong and M. J. Postma

Prescription opioids and economic hardship in France pp. 1473-1504

Ilaria Natali, Mathias Dewatripont, Victor Ginsburgh, Michel Goldman and Patrick Legros

Identifying factors associated with high use of acute care in Canada: a population-based retrospective study pp. 1505-1515

Mengmeng Zhang, Jinhui Ma, Feng Xie and Lehana Thabane

Population norms in France with EQ-5D-5L: health states, value indexes, and VAS pp. 1517-1530

Laurène Gautier, Jessica Azzi, Grèce Saba, Geneviève Bonnelye and Gérard Pouvourville

The social value of gambling: surplus estimates by gambling types for France pp. 1531-1543

Maxence Miéra, Sophie Massin and Vincent Eroukmanoff

Cost and cost-effectiveness of four different SARS-CoV-2 active surveillance strategies: evidence from a randomised control trial in Germany pp. 1545-1559

Hoa Thi Nguyen, Claudia M. Denkinger, Stephan Brenner, Lisa Koeppel, Lucia Brugnara, Robin Burk, Michael Knop, Till Bärnighausen, Andreas Deckert and Manuela De Allegri

Does uptake of specialty care affect HRQoL development in COPD patients beneficially? A difference-in-difference analysis linking claims and survey data pp. 1561-1573

Alisa Stöber, Pavo Marijic, Christoph Kurz, Larissa Schwarzkopf, Florian Kirsch, Anja Schramm and Reiner Leidl

Driving time drives the hospital choice: choice models for pelvic organ prolapse surgery in Italy pp. 1575-1586

Amerigo Ferrari, Chiara Seghieri, Andrea Giannini, Paolo Mannella, Tommaso Simoncini and Milena Vainieri

Volume 24, issue 8, 2023

Modeling European health systems: a theoretical exercise pp. 1249-1252

L. Garattini and Marco Badinella Martini

To what extent does the use of crosswalks instead of EQ-5D value sets impact reimbursement decisions?: a simulation study pp. 1253-1270

Ângela Jornada Ben, Johanna M. Dongen, Aureliano Paolo Finch, Mohamed El Alili and Judith E. Bosmans

The effect of hepatitis C—associated premature deaths on labour productivity losses in Spain: a ten-year analysis pp. 1271-1283

L. M. Peña-Longobardo, J. Oliva-Moreno and C. Fernández-Rodriguez

Developing an Australian utility value set for the Early Childhood Oral Health Impact Scale-4D (ECOHIS-4D) using a discrete choice experiment pp. 1285-1296

Ruvini M. Hettiarachchi, Peter Arrow, Sameera Senanayake, Hannah Carter, David Brain, Richard Norman, Utsana Tonmukayawul, Lisa Jamieson and Sanjeewa Kularatna

Assessment of health-related quality of life in individuals with depressive symptoms: validity and responsiveness of the EQ-5D-3L and the SF-6D pp. 1297-1307

Maike Stolz, Christian Albus, Manfred E. Beutel, Hans-Christian Deter, Kurt Fritzsche, Christoph Herrmann-Lingen, Matthias Michal, Katja Petrowski, Joram Ronel, Jobst-Hendrik Schultz, Wolfgang Söllner, Cora Weber, Martina Zwaan and Christian Krauth

Out-of-pocket costs sustained in the last 12 months by cancer patients: an Italian survey-based study on individual expenses between 2017 and 2018 pp. 1309-1319

Roberto Lillini, Francesco De Lorenzo, Paolo Baili, Elisabetta Iannelli, Laura M. Del Campo, Dina Pero, Gianfranca Traclò, Alessandro Sproviero, Milena Sant and Francesco Perrone

Social costs of obesity in the Czech Republic pp. 1321-1341

Petra Landovská and Martina Karbanová

Cost–benefit analysis of the CoCare intervention to improve medical care in long-term care nursing homes: an analysis based on claims data pp. 1343-1355

Boris A. Brühmann, Klaus Kaier, Rieka Warth and Erik Farin-Glattacker

Excess costs of multiple sclerosis: a register-based study in Sweden pp. 1357-1371

Chantelle Murley, Petter Tinghög, Fitsum Sebsibe Teni, Alejandra Machado, Kristina Alexanderson, Jan Hillert, Korinna Karampampa and Emilie Friberg

Significant healthcare burden and life cost of spinal muscular atrophy: real-world data pp. 1373-1382

Sophelia H. S. Chan, Carlos K. H. Wong, Tingting Wu, Wilfred Wong, Michael K. L. Yu, Ivan C. H. Au and Godfrey C. F. Chan

Insurance coverage, long-term care utilization, and health outcomes pp. 1383-1397

Masaki Takahashi

EQ-5D and SF-6D health utility scores in patients with spinal and bulbar muscular atrophy pp. 1399-1410

Richard Huan Xu, Ming Lu, Shuyang Zhang and Dong Dong

Volume 24, issue 7, 2023

Competition and collaboration in health care: reconciling the irreconcilable? Lessons from The Netherlands pp. 1019-1021

Marco Varkevisser, Frédérique Franken, Stéphanie Geest and Erik Schut

Health technology assessment criteria as drivers of coverage with managed entry agreements: a case study of cancer medicines in four countries pp. 1023-1031

Olina Efthymiadou

The cost-effectiveness of a uniform versus age-based threshold for one-off screening for prevention of cardiovascular disease pp. 1033-1045

Zuzana Špacírová, Stephen Kaptoge, Leticia García-Mochón, Miguel Rodríguez Barranco, María José Sánchez Pérez, Nicola P. Bondonno, Anne Tjønneland, Elisabete Weiderpass, Sara Grioni, Jaime Espín, Carlotta Sacerdote, Catarina Schiborn, Giovanna Masala, Sandra M. Colorado-Yohar, Lois Kim, Karel G. M. Moons, Gunnar Engström, Matthias B. Schulze, Léa Bresson, Concepción Moreno-Iribas and David Epstein

Estimating healthcare expenditures after becoming divorced or widowed using propensity score matching pp. 1047-1060

Iris Meulman, Bette Loef, Niek Stadhouders, Tron Anders Moger, Albert Wong, Johan J. Polder and Ellen Uiters

Mapping analysis to predict SF-6D utilities from health outcomes in people with focal epilepsy pp. 1061-1072

India Flint, Jasmina Medjedovic, Ewa Drogon O’Flaherty, Elena Alvarez-Baron, Karthinathan Thangavelu, Natasa Savic, Aurelie Meunier and Louise Longworth

Out-of-pocket expenses of patients with inflammatory bowel disease: a comparison of patient-reported outcomes across 12 European countries pp. 1073-1083

Przemysław Holko, Paweł Kawalec, Magdalena Sajak-Szczerba, Luisa Avedano and Małgorzata Mossakowska

Do not PIMP my nursing home ride! The impact of Potentially Inappropriate Medications Prescribing on residents’ emergency care use pp. 1085-1100

Thomas Rapp, Jonathan Sicsic, Neda Tavassoli and Yves Rolland

The effects of an increase in the retirement age on health care costs: evidence from administrative data pp. 1101-1120

Johannes Geyer, Mara Barschkett, Peter Haan and Anna Hammerschmid

The economic burden of idiopathic pulmonary fibrosis in Australia: a cost of illness study pp. 1121-1139

Ingrid A. Cox, Barbara Graaff, Hasnat Ahmed, Julie Campbell, Petr Otahal, Tamera J. Corte, Yuben Moodley, Nicole Goh, Peter Hopkins, Sacha Macansh, E. Haydn Walters and Andrew J. Palmer

Can drones save lives and money? An economic evaluation of airborne delivery of automated external defibrillators pp. 1141-1150

Johann W. A. Röper, Katharina Fischer, Mina Carolina Baumgarten, Karl Christian Thies, Klaus Hahnenkamp and Steffen Fleßa

The estimation of health state utility values in rare diseases: do the approaches in submissions for NICE technology appraisals reflect the existing literature? A scoping review pp. 1151-1216

Michela Meregaglia, Elena Nicod and Michael Drummond

What if 0 is not equal to 0? Inter-personal health utilities anchoring using the largest health gains pp. 1217-1233

Michał Jakubczyk

“COVID-19 and income inequality in OECD countries:” A methodological comment pp. 1235-1237

Oded Stark

COVID-19 and income inequality in OECD countries: a methodological comment—a reply pp. 1239-1241

John Wildman

Impact of the introduction of the AMNOG law on launch delays of new drugs in Germany: a comment pp. 1243-1244

Afschin Gandjour

Does health technology assessment compromise access to pharmaceuticals? pp. 1245-1248

Melanie Büssgen and Tom Stargardt

Volume 24, issue 6, 2023

Trends and drivers of pharmaceutical expenditures from systemic anti-cancer therapy pp. 853-865

Lars Børty, Rasmus F. Brøndum, Heidi S. Christensen, Charles Vesteghem, Marianne Severinsen, Søren P. Johnsen, Lars H. Ehlers, Ursula Falkmer, Laurids Ø. Poulsen and Martin Bøgsted

Apixaban versus other anticoagulants in patients with nonvalvular fibrillation: a comparison of all-cause and event-related costs in real-life setting in France pp. 867-875

Manon Belhassen, Olivier Hanon, Philippe Gabriel Steg, Isabelle Mahé, Mélanie Née, Flore Jacoud, Faustine Dalon, François-Emery Cotté, Dominique Guitard-Dehoux, Claire Marant-Micallef, Eric Van Ganse and Nicolas Danchin

Completing the time trade-off with respondents who are older, in poorer health or with an immigrant background in an EQ-5D-5L valuation study pp. 877-884

Tonya Moen Hansen, Knut Stavem and Kim Rand

Comparison of EQ-5D-5L and EORTC QLU-C10D utilities in gastric cancer patients pp. 885-893

Chen-Wei Pan, Jun-Yi He, Yan-Bo Zhu, Chun-Hua Zhao, Nan Luo and Pei Wang

The long-term cost-effectiveness of once-weekly semaglutide 1 mg vs. dulaglutide 3 mg and 4.5 mg in the UK pp. 895-907

Adie Viljoen, Barrie Chubb, Samuel J. P. Malkin, Sasha Berry, Barnaby Hunt and Stephen C. Bain

Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC4E trial in 15 European countries pp. 909-922

Xiao Li, Joke Bilcke, Alike W. van der Velden, Robin Bruyndonckx, Samuel Coenen, Emily Bongard, Muirrean de Paor, Slawomir Chlabicz, Maciek Godycki-Cwirko, Nick Francis, Rune Aabenhus, Heiner C. Bucher, Annelies Colliers, An De Sutter, Ana Garcia-Sangenis, Dominik Glinz, Nicolay J. Harbin, Katarzyna Kosiek, Morten Lindbæk, Christos Lionis, Carl Llor, Réka Mikó-Pauer, Ruta Radzeviciene Jurgute, Bohumil Seifert, Pär-Daniel Sundvall, Pia Touboul Lundgren, Nikolaos Tsakountakis, Theo J. Verheij, Herman Goossens, Christopher C. Butler and Philippe Beutels

Do mobile hospital teams in residential aged care facilities increase health care efficiency: an evaluation of French residential care policy pp. 923-937

Anne Penneau

Using the EQ-5D-5L to investigate quality-of-life impacts of disease-modifying therapy policies for people with multiple sclerosis (MS) in New Zealand pp. 939-950

Suzi Claflin, Julie Campbell, Richard Norman, Deborah F. Mason, Tomas Kalincik, Steve Simpson-Yap, Helmut Butzkueven, William M. Carroll, Andrew J. Palmer, C. Leigh Blizzard, Ingrid van der Mei, Glen J. Henson and Bruce V. Taylor

The handling of missing data in trial-based economic evaluations: should data be multiply imputed prior to longitudinal linear mixed-model analyses? pp. 951-965

Ângela Jornada Ben, Johanna M. Dongen, Mohamed El Alili, Martijn W. Heymans, Jos W. R. Twisk, Janet L. MacNeil-Vroomen, Maartje Wit, Susan E. M. Dijk, Teddy Oosterhuis and Judith E. Bosmans

Willingness to pay for health gains from an international integrated early warning system for infectious disease outbreaks pp. 967-986

Meg Perry-Duxbury, Sebastian Himmler, Job Exel and Werner Brouwer

The application of discrete choice experiments eliciting young peoples’ preferences for healthcare: a systematic literature review pp. 987-998

Galina Williams and Irina Kinchin

Does competition improve hospital performance: a DEA based evaluation from the Netherlands pp. 999-1017

Peter Dohmen, Martin Ineveld, Aniek Markus, Liana Hagen and Joris Klundert

Volume 24, issue 5, 2023

Does diagnostic testing always decrease antibiotics prescriptions? pp. 673-678

F. Antoñanzas, C. A. Juárez-Castelló and R. Rodríguez-Ibeas

The ‘welcomed lockdown’ hypothesis? Mental wellbeing and mobility restrictions pp. 679-699

Joan Costa-Font, Martin Knapp and Cristina Vilaplana-Prieto

Future medical and non-medical costs and their impact on the cost-effectiveness of life-prolonging interventions: a comparison of five European countries pp. 701-715

Hamraz Mokri, Ingelin Kvamme, Linda Vries, Matthijs Versteegh and Pieter Baal

Assessing Taiwan’s pay-for-performance program for diabetes care: a cost–benefit net value approach pp. 717-733

Jui-fen Rachel Lu, Ying Isabel Chen, Karen Eggleston, Chih-Hung Chen and Brian Chen

Assessing the cost-effectiveness of COVID-19 vaccines in a low incidence and low mortality setting: the case of Thailand at start of the pandemic pp. 735-748

Yi Wang, Nantasit Luangasanatip, Wirichada Pan–ngum, Wanrudee Isaranuwatchai, Juthamas Prawjaeng, Sompob Saralamba, Christopher Painter, Jamaica Roanne Briones and Yot Teerawattananon

Were we happy and we didn’t know it? A subjective dynamic and financial assessment pre-, during and post-COVID-19 pp. 749-768

Gabriela-Mihaela Mureșan, Viorela-Ligia Văidean, Codruța Mare and Monica Violeta Achim

Obesity and metabolic state are associated with increased healthcare resource and medication use and costs: a Finnish population-based study pp. 769-781

Aino Vesikansa, Juha Mehtälä, Katja Mutanen, Annamari Lundqvist, Tiina Laatikainen, Tero Ylisaukko-oja, Tero Saukkonen and Kirsi H. Pietiläinen

Cost-effectiveness of the MitraClip device in secondary mitral regurgitation: comment upon the article by Estler et al pp. 783-784

Martin Connock and Xavier Armoiry

An econometric approach to aggregating multiple cardiovascular outcomes in German hospitals pp. 785-802

Angela Meggiolaro, Carl Blankart, Tom Stargardt and Jonas Schreyögg

Dividend policy issues in the European pharmaceutical industry: new empirical evidence pp. 803-816

Tobias Basse, Christoph Schwarzbach and J.-Matthias Schulenburg

“The reputation premium”: does hospital ranking improvement lead to a higher healthcare spending? pp. 817-830

Jinyang Chen and Chaoqun Wang

Estimating the willingness-to-pay to avoid the consequences of foodborne illnesses: a discrete choice experiment pp. 831-852

Kathleen Manipis, Brendan Mulhern, Philip Haywood, Rosalie Viney and Stephen Goodall

Volume 24, issue 4, 2023

Tenders for generics and biosimilars: a challenging purchasing policy pp. 485-487

Fernando Antoñanzas, Carmelo Juárez-Castelló and Roberto Rodríguez-Ibeas

Inpatient care utilisation and expenditure associated with objective physical activity: econometric analysis of the UK Biobank pp. 489-497

Leonie Heron, Mark A. Tully, Frank Kee and Ciaran O’Neill

Psychometric evaluation of the German version of the Recovering Quality of Life (ReQoL) measures in patients with affective disorders pp. 499-512

Thomas Grochtdreis, Hans-Helmut König, Anju Devianee Keetharuth, Jürgen Gallinat, Alexander Konnopka, Holger Schulz, Martin Lambert, Anne Karow and Judith Dams

Lifetime direct healthcare costs of treating colorectal cancer: a systematic review pp. 513-537

Nazim Bhimani, Geoffrey YM Wong, Charles Molloy, Mbathio Dieng, Patrick J Kelly and Thomas J Hugh

Sex differences in care complexity and cost of cardiac-related procedures as a basis for improving hospital payments systems pp. 539-556

Shuli Brammli-Greenberg, Sharvit Fialco, Neria Shtauber and Yoram Weiss

Obesity and labour market outcomes in Italy: a dynamic panel data evidence with correlated random effects pp. 557-574

Antonio Pacifico

Cost-effectiveness of metabolic surgery for the treatment of type 2 diabetes and obesity: a systematic review of economic evaluations pp. 575-590

Karen Jordan, Christopher G. Fawsitt, Paul G. Carty, Barbara Clyne, Conor Teljeur, Patricia Harrington and Mairin Ryan

The pass-through of excise taxes to market prices of heated tobacco products (HTPs) and cigarettes: a cross-country analysis pp. 591-607

Estelle Dauchy and Ce Shang

Estimating loss in capability wellbeing in the first year of the COVID-19 pandemic: a cross-sectional study of the general adult population in the UK, Australia and the Netherlands pp. 609-619

Paul Mark Mitchell, Rachael L. Morton, Mickaël Hiligsmann, Samantha Husbands and Joanna Coast

Modeling the potential efficiency of a blood biomarker-based tool to guide pre-hospital thrombolytic therapy in stroke patients pp. 621-632

Elizabeth Parody-Rua, Alejandro Bustamante, Joan Montaner, Maria Rubio-Valera, David Serrano, Soledad Pérez-Sánchez, Alba Sánchez-Viñas, César Guevara-Cuellar and Antoni Serrano-Blanco

A novel mathematical model for prioritization of individuals to receive vaccine considering governmental health protocols pp. 633-646

N. Shamsi Gamchi and M. Esmaeili

Reducing the basic reproduction number of COVID-19: a model simulation focused on QALYs, hospitalisation, productivity costs and optimal (soft) lockdown pp. 647-659

Jose Robles-Zurita

Letter to the Editor: Lazzaro responds to Rodríguez‑Sánchez et al pp. 661-662

Carlo Lazzaro

Response letter for the comment made on our article entitled “Does the inclusion of societal costs change the economic evaluations recommendations? A systematic review for multiple sclerosis disease”, published online last May in the European Journal of Health Economics, doi: 10.1007/s10198-022-01471-9 pp. 663-672

Juan Oliva-Moreno

Volume 24, issue 3, 2023

Assessing the treatment pattern, health care resource utilisation, and economic burden of multiple myeloma in France using the Système National des Données de Santé (SNDS) database: a retrospective cohort study pp. 321-333

Antoine Bessou, Xavier Colin, Julie De Nascimento, Will Sopwith, Shannon Ferrante, Boris Gorsh, Benjamin Gutierrez, Leah Sansbury, Jenny Willson, Sandhya Sapra, Prani Paka and Feng Wang

Live and let live: understanding the temporal drivers and spillovers of life expectancy in Europe for public planning pp. 335-347

Pilar Gracia- de-Rentería, Hugo Ferrer-Pérez, Ana Isabel Sanjuán and George Philippidis

Cost-effectiveness of the MitraClip device in German heart failure patients with secondary mitral regurgitation pp. 349-358

Bent Estler, Volker Rudolph, Yana Seleznova, Arim Shukri, Stephanie Stock and Dirk Müller

Transcatheter aortic valve implantation in patients with severe symptomatic aortic valve stenosis: systematic review of cost-effectiveness analysis pp. 359-376

Phatcharaphorn Chotnoppharatphatthara, Voratima Yoodee, Suthinee Taesotikul, Jirawit Yadee and Unchalee Permsuwan

A systematic review of the cost-effectiveness of renal replacement therapies, and consequences for decision-making in the end-stage renal disease treatment pathway pp. 377-392

Ellen Busink, Dana Kendzia, Fatih Kircelli, Sophie Boeger, Jovana Petrovic, Helen Smethurst, Stephen Mitchell and Christian Apel

A hearing bolt-on item increased the measurement properties of the EQ-5D-5L in a community-based hearing loss screening program pp. 393-398

Pei Wang, Sheue-Lih Chong, Rachel Lee-Yin Tan and Nan Luo

EQ-5D-5L: a value set for Romania pp. 399-412

Elena Olariu, Wael Mohammed, Yemi Oluboyede, Raluca Caplescu, Ileana Gabriela Niculescu-Aron, Marian Sorin Paveliu and Luke Vale

Do preferences differ based on respondent experience of a health issue and its treatment? A case study using a public health intervention pp. 413-423

David J. Mott, Laura Ternent and Luke Vale

Willingness to provide informal care to older adults in Germany: a discrete choice experiment pp. 425-436

Lea de Jong, Torben Schmidt, Jona Theodor Stahmeyer, Sveja Eberhard, Jan Zeidler and Kathrin Damm

Does health technology assessment compromise access to pharmaceuticals? pp. 437-451

Melanie Büssgen and Tom Stargardt

Model parameters influencing the cost-effectiveness of sacubitril/valsartan in heart failure: evidence from a systematic literature review pp. 453-467

Clare Proudfoot, Raju Gautam, Joaquim Cristino, Rumjhum Agrawal, Lalit Thakur and Keith Tolley

Impact of a diabetes disease management program on guideline-adherent care, hospitalization risk and health care costs: a propensity score matching study using real-world data pp. 469-478

Marc Höglinger, Brigitte Wirth, Maria Carlander, Cornelia Caviglia, Christian Frei, Birgitta Rhomberg, Adrian Rohrbasser, Maria Trottmann and Klaus Eichler

Making the rules make sense: valuation of constrained resources pp. 479-481

Jonathan Siverskog

Reply to: making the rules make sense: valuation of constrained resources pp. 483-483

Peter Lindgren

Volume 24, issue 2, 2023

General practice in the EU: countries you see, customs you find pp. 153-156

Livio Garattini, Marco Badinella Martini and Alessandro Nobili

Survival analysis of cancer patients in Portugal following the reference centre model implementation pp. 157-168

Manuel Melo Mateus, Margarida Catalão-Lopes and Rui Portugal

Healthcare costs of diabetic foot disease in Italy: estimates for event and state costs pp. 169-177

Chiara Seghieri, Francesca Ferrè, Elisa Foresi and Alice Borghini

Does a working day keep the doctor away? A critical review of the impact of unemployment and job insecurity on health and social care utilisation pp. 179-186

Keyi Li, Paula Lorgelly, Sarah Jasim, Tiyi Morris and Manuel Gomes

Disutility of injectable therapies in obesity and type 2 diabetes mellitus: general population preferences in the UK, Canada, and China pp. 187-196

Phil McEwan, James Baker-Knight, Björg Ásbjörnsdóttir, Yunni Yi, Aimee Fox and Robin Wyn

Comparing EQ-5D-3L and EQ-5D-5L in measuring the HRQoL burden of 4 health conditions in China pp. 197-207

Guizhi Weng, Yanming Hong, Nan Luo, Clara Mukuria, Jie Jiang, Zhihao Yang and Sha Li

The association between bed occupancy rates and hospital quality in the English National Health Service pp. 209-236

Laia Bosque-Mercader and Luigi Siciliani

Is ultra-hypo-fractionated radiotherapy more cost-effective relative to conventional fractionation in treatment of prostate cancer? A cost–utility analysis alongside a randomized HYPO-RT-PC trial pp. 237-246

Sun Sun, Håkan Jonsson, Klas-Göran Salén, Mats Andén, Lars Beckman and Per Fransson

Does the inclusion of societal costs change the economic evaluations recommendations? A systematic review for multiple sclerosis disease pp. 247-277

B. Rodríguez-Sánchez, S. Daugbjerg, L. M. Peña-Longobardo, J. Oliva-Moreno, I. Aranda-Reneo, A. Cicchetti and J. López-Bastida

Mapping the obesity problems scale to the SF-6D: results based on the Scandinavian Obesity Surgery Registry (SOReg) pp. 279-292

Sun Sun, Erik Stenberg, Yang Cao, Lars Lindholm, Klas-Göran Salén, Karl A. Franklin and Nan Luo

Time and lexicographic preferences in the valuation of EQ-5D-Y with time trade-off methodology pp. 293-305

Stefan A. Lipman, Liying Zhang, Koonal K. Shah and Arthur Attema

Understanding bias in probabilistic analysis in model-based health economic evaluation pp. 307-319

Xuanqian Xie, Alexis K. Schaink, Sichen Liu, Myra Wang and Andrei Volodin

Volume 24, issue 1, 2023

Patient-reported measures: how useful in health economics? pp. 1-4

Anne-Gaëlle Corroller and Julia Bonastre

On absolute socioeconomic health inequality comparisons pp. 5-25

Mohamad Khaled, Paul Makdissi and Myra Yazbeck

Health state utilities for beta-thalassemia: a time trade-off study pp. 27-38

Antony P. Martin, Enrico Ferri Grazzi, Claudia Mighiu, Manoj Chevli, Farrukh Shah, Louise Maher, Anum Shaikh, Aliah Sagar, Hayley Hubberstey, Bethany Franks, Juan M. Ramos-Goñi, Mark Oppe and Derek Tang

Vaccination or NPI? A conjoint analysis of German citizens' preferences in the context of the COVID-19 pandemic pp. 39-52

Jacques Bughin, Michele Cincera, Evelyn Kiepfer, Dorota Reykowska, Florian Philippi, Marcin Żyszkiewicz, Rafal Ohme and Dirk Frank

Complexities of health and acceptance of electronic health records for the Austrian elderly population pp. 53-66

Nicole Halmdienst, Gerald Pruckner and Rudolf Winter-Ebmer

The common interests of health protection and the economy: evidence from scenario calculations of COVID-19 containment policies pp. 67-74

Florian Dorn, Sahamoddin Khailaie, Marc Stoeckli, Sebastian C. Binder, Tanmay Mitra, Berit Lange, Stefan Lautenbacher, Andreas Peichl, Patrizio Vanella, Timo Wollmershäuser, Clemens Fuest and Michael Meyer-Hermann

Hospital resource utilisation from HPV-related diseases in England: a real-world cost analysis pp. 75-80

G. Fabiano, A. Marcellusi, Francesco Saverio Mennini, P. Sciattella and G. Favato

Preferences for COVID-19 epidemic control measures among French adults: a discrete choice experiment pp. 81-98

Jonathan Sicsic, Serge Blondel, Sandra Chyderiotis, Francois Langot and Judith E. Mueller

Inequality, public health, and COVID-19: an analysis of the Spanish case by municipalities pp. 99-110

Ignacio Amate-Fortes and Almudena Guarnido-Rueda

The goal of risk equalization in regulated competitive health insurance markets pp. 111-123

Wynand Ven, Gerrit Hamstra, Richard Kleef, Mieke Reuser and Piet Stam

Financial risk allocation and provider incentives in hospital–insurer contracts in The Netherlands pp. 125-138

Chandeni S. Gajadien, Peter J. G. Dohmen, Frank Eijkenaar, Frederik T. Schut, Erik M. Raaij and Richard Heijink

Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L descriptive systems and utilities in atopic dermatitis pp. 139-152

Kamilla Koszorú, Krisztina Hajdu, Valentin Brodszky, Alex Bató, L. Hunor Gergely, Anikó Kovács, Zsuzsanna Beretzky, Miklós Sárdy, Andrea Szegedi and Fanni Rencz